Patent · US Active

Cationic lipids for therapeutic agent delivery formulations

US10532975B2 · kind B2 · utility

0Cited by
36References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2018
Grant dateJan 14, 2020
Priority date
Expiry dateMar 12, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/113
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Here described is a method of delivery of a drug to a stellate cell using a composition comprising a compound of formula I: wherein R1 and R2 are independently selected from C10 to C18 alkyl, C12 to C18 alkenyl, and oleoyl; R3 and R4 are independently selected from C1 to C6 alkyl and C2 to C6 alkanol; X is selected from —CH2—, —S—, and —O—, or X is absent; Y is selected from —(CH2)n, —S(CH2)n—, —O(CH2)n—, -thiophene-, —SO2(CH2)n—, and ester; n═1-4; a═1-4; b═1-4; c═1-4; and Z− is a counterion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.